FDA: Page 3
FDA Grants 23andMe Approval to Sell Test for Rare Genetic Condition
It's a small but definite step towards 23andMe's goal of selling DNA kits again.
23andMe's Database of Genetic Information Is Going to Make It Lots of Money
The company just announced a lucrative deal with the biotech firm Genetech, and says many similar deals are in the works.
U.S. Chain Restaurants Will Be Required to Disclose Calorie Counts on Menus
Sweeping new rules form the FDA aim to make people more aware of the risks of obesity posed by fatty, sugary foods.
Google Is Interested in Your Health, But Deterred by Regulations
In an extensive interview with venture capitalist Vinod Khosla, Google founders Sergey Brin and Larry Page explained why regulations are hampering improvements in health care.
Restaurants Seek Alternatives as FDA's Salt Crackdown Looms
As the FDA prepares new guidelines, restaurants are cutting back on sodium and salt companies are researching alternatives.
FDA Backs Off After Causing Stink Over Cheese Regulations
Recent communication from regulators sparked concerns that the government would ban cheese from being made on wooden shelves.
When Is Hummus Not Hummus? When Regulators Say So.
Sabra, the popular hummus producer, is pushing the Food and Drug Administration to set a definition for the dip.
Would You Sip on Drinkable Sunscreen?
Gross as it may sounds, a cosmetics company claims to have created a drinkable sunscreen that can block the sun.
FDA Approves First Mind-Controlled Prosthetic Arm
The arm allows amputees to perform once impossible tasks, like using a zipper and picking up delicate objects like grapes and eggs.
U.S. Nutrition Labels Get a Makeover, But New Version Won't Be Seen for Years
The FDA's proposed new nutrition labels intend to make healthy shopping easier for families, saving on health-care costs in the long run.
In Taking Aim at 23andMe, Regulators Missed the Mark
The controversy over genetic-testing company 23andMe begs the question: Is knowledge really that dangerous?
FDA Ban Is the Final Nail in Trans Fat's Coffin
The FDA's decision to phase out trans fats has been met with little resistance, due to easy substitutes and consensus on the ingredient's unhealthiness.
FDA Steps up Oversight on Medical Apps
Until now, the the Food & Drug Administration has taken a largely hands-off approach to medical apps. For those entrepreneurs who are subject to FDA scrutiny, however, the process can be daunting.